Femasys (FEMY) Asset Writedowns and Impairment (2024 - 2025)
Femasys posted quarterly Asset Writedowns and Impairment of -$5000.0 for Q1 2025, down 600.0% year-on-year from $1000.0 in Q1 2024, and down 350.0% on a QoQ basis from $2000.0 in Q4 2024.
Femasys (FEMY) has 2 years of Asset Writedowns and Impairment data on file, last reported at -$5000.0 in Q1 2025.
- For the quarter ending Q1 2025, Asset Writedowns and Impairment fell 600.0% year-over-year to -$5000.0; the trailing twelve-month figure through Mar 2025 stood at -$2000.0 (changed N/A YoY), and the FY2024 full-year result was $8000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at -$5000.0, down from $2000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2000.0 in Q4 2024 and bottomed at -$5000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |